This might be retail dragging this down or someone keeping it down for a TO. They're an easy target for BO now. Considering this FDA approval was for a product that worked better than it's competition, I would not be surprised at a TO bid.
Ann: Orthocell Receives First US CelGro Product Approval, page-147
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
63.5¢ |
Change
-0.025(3.79%) |
Mkt cap ! $133.0M | |||
| Open | High | Low | Value | Volume |
| 68.0¢ | 69.5¢ | 60.5¢ | $1.103M | 1.734M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | 63.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 65.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| OCC (ASX) Chart |